Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
Locations
Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
BGB-A317-fruquintinib-201
Recruiting
Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors
Beigene Study ID
BGB-A317-fruquintinib-201
ClinicalTrials.gov ID
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents